|Author:||Sorting Last Post on Top ↓ Message:||
It seems like some of the medications out there have such nasty "possible" side effects that it sure would make you think twice about using the medication. You would think that they could come up with better medications that doesn't have such horrible "possible" side effects. My favorite is the medication you see advertised all the time that is suppose to help treat ADHD. One of the "rare" but "possible" side effects is sudden death! Yeah, that's totally worth it to help treat someone's ADHD!!
Cathy (Central Time Zone)
A&I BSG Stunning StrawberriesTeam
"Don't Let School Get in the Way of Your Education." - Mark Twain
Aspire & Inspire team co-leader
Ugh, don't you hate the side effects? At least they let people know - sometimes the medication choices are to choose the lesser of several evils.
"Dance as if no one is watching."
Wow, those are not good side effects, but then again, most drugs anymore have a long list.
April 22, 2013
FDA Updates Atripla Label
The U.S. Food and Drug Administration (FDA) has made changes to the label for the single-pill HIV antiretroviral combination therapy Atripla (efavirenz/emtricitabine/tenofovir). Among those changes and additions are:
An advisory against taking Atripla with Stribild (elvitegravir/cobicistat/emtricitabine/ten
Information on drug interaction for raltegravir, boceprevir and telaprevir.
Additional information about a rash warning, advising those with a life-threatening reaction such as Stevens-Johnson syndrome to consider alternative HIV therapy.
A statement that the appropriate dosing for a combination of efavirenz and boosted Invirase (saquinavir/ritonavir) has not been established.
Information about dosing with boosted Kaletra (lopinavir/ritonavir), with an advisory that those taking the pair in combination with Atripla should be monitored for adverse reactions.
In an addition to the advisory that HIV-positive mothers should not breast-feed their infants because of the risk of transmitting the virus, the FDA states that studies in rats have shown that efavirenz is secreted in milk and that human studies have shown that both tenofovir and emtricitabine are excreted in breast milk. Because the risks of infant exposure to these agents are unknown, mothers should not breast-feed while taking Atripla.
"How far that little candle throws its beams! So shines a good deed in a naughty world."
|Searching for HIV in Timothy Brown, the Berlin P||6/24/2013 9:14:27 PM|
|60 Times Larger||11/8/2013 10:01:57 AM|
|Advice on Having Safer Sex With HIV-Negative Partn||7/21/2013 5:29:26 PM|
|If, When, Where and How to Say "I Have HIV"||9/1/2013 11:43:27 AM|
|Plant-Based Compound May Inhibit HIV||7/30/2013 2:55:58 AM|